Insider Transactions Reported by 20 Insiders of Harmony Biosciences Holdings, Inc.

Symbol
HRMY on Nasdaq
Location
Plymouth Meeting, PA

Insiders trading volume in the past year

Harmony Biosciences Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Marshman Fund Trust II 10%+ Owner $183,364,064 01 Nov 2024
Andreas Wicki Director $71,655,378 12 Dec 2022
Jeffrey M. Dayno PRESIDENT, CEO, Director $2,249,329 -$1,040,103 -32% 22 Jan 2026
Sandip Kapadia Chief Financial Officer $1,409,457 -$2,817,609 -67% 26 Jan 2026
Adam H. Zaeske Chief Commercial Officer $993,456 22 Jan 2026
Valor IV Pharma Holdings, LLC 10%+ Owner $834,732 28 Aug 2025
Jeffrey Dierks Chief Commercial Officer $511,837 03 Mar 2025
Andrew Serafin Chief Strategy Officer $471,633 22 Jan 2026
Kumar Budur Chief Medical Officer $452,453 22 Jan 2026
Jack Nielsen Director 29 May 2024
Antonio J. Gracias Director 15 May 2025
JEFFREY S. ARONIN Director 24 Mar 2022
Juan A. Sabater Director 15 May 2025
Ron M. Philip Director 15 May 2025
Peter Anastasiou Director 15 May 2025
Gary Sender Director 15 May 2025
Eric L. Motley Director 20 May 2021
R. Mark Graf Director 15 May 2025
Linda M. Szyper Director 15 May 2025
John C. Jacobs PRESIDENT, CEO, Director 15 Aug 2022

Recent Insider Transactions by Companies or Individuals for Harmony Biosciences Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.